Rankings
▼
Calendar
AMRN Q3 2020 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$156M
+39.2% YoY
Gross Profit
$123M
78.9% margin
Operating Income
-$7M
-4.4% margin
Net Income
-$7M
-4.3% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+15.7%
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$11M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$960M
Total Liabilities
$353M
Stockholders' Equity
$607M
Cash & Equivalents
$207M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$156M
$112M
+39.2%
Gross Profit
$123M
$87M
+41.9%
Operating Income
-$7M
-$5M
-53.6%
Net Income
-$7M
-$3M
-96.1%
Revenue Segments
Product
$155M
99%
Licensing And Royalty
$1M
1%
← FY 2020
All Quarters
Q4 2020 →